Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05732831
What this trial is testing

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

Who this might be right for
Locally Advanced Solid Tumor
Tango Therapeutics, Inc. 225
Testing effectiveness (Phase 2)Study completedNCT00952731
What this trial is testing

4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ

Who this might be right for
Ductal Breast Carcinoma in SituEstrogen Receptor-positive Breast Cancer
Northwestern University 27
Early research (Phase 1)Study completedNCT04750473
What this trial is testing

Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Invasive Breast Lobular CarcinomaMetastatic Breast Lobular Carcinoma+1 more
Emory University 20
Large-scale testing (Phase 3)Study completedNCT00002920
What this trial is testing

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

Who this might be right for
Breast CancerEndometrial Cancer
SWOG Cancer Research Network 313
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Ended earlyNCT05714553
What this trial is testing

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Who this might be right for
Advanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more
NuCana plc 19
Testing effectiveness (Phase 2)Ended earlyNCT02127073
What this trial is testing

Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer

Who this might be right for
Breast CancerDuctal Carcinoma in Situ
Montefiore Medical Center 8
Testing effectiveness (Phase 2)Ended earlyNCT04260802
What this trial is testing

Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

Who this might be right for
CancerNeoplasmsMetastatic Cancer+16 more
Ocellaris Pharma, Inc. 73
Large-scale testing (Phase 3)Temporarily pausedNCT02037529
What this trial is testing

Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer

Who this might be right for
Breast AdenocarcinomaHER2/Neu NegativeInvasive Breast Carcinoma+2 more
Academic and Community Cancer Research United 201
Not applicableUnknownNCT00967239
What this trial is testing

Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2

Who this might be right for
Breast Cancer
NSABP Foundation Inc 1,881
Early research (Phase 1)UnknownNCT02637531
What this trial is testing

A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549

Who this might be right for
Advanced Solid Tumors (Part A/B/C/D)Non-small Cell Lung Cancer (Part E)Melanoma (Part E)+5 more
Infinity Pharmaceuticals, Inc. 219
Early research (Phase 1)Study completedNCT00019019
What this trial is testing

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more
National Institutes of Health Clinical Center (CC) 70
Early research (Phase 1)Ended earlyNCT03432741
What this trial is testing

Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer

Who this might be right for
Breast AdenocarcinomaMetastatic Breast CarcinomaRecurrent Breast Carcinoma+11 more
Mayo Clinic 17
Early research (Phase 1)Study completedNCT02206334
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer

Who this might be right for
Male Breast CarcinomaProstate AdenocarcinomaRecurrent Breast Carcinoma+5 more
NRG Oncology 42
Early research (Phase 1)Study completedNCT03517488
What this trial is testing

XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Who this might be right for
MelanomaBreast CarcinomaHepatocellular Carcinoma+25 more
Xencor, Inc. 150
Not applicableStudy completedNCT02121873
What this trial is testing

The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage

Who this might be right for
Breast CancerPreneoplastic ConditionsDuctal Carcinoma in Situ
Atossa Therapeutics, Inc. 6
Not applicableStudy completedNCT05086705
What this trial is testing

EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer

Who this might be right for
Breast CarcinomaBreast Ductal Carcinoma In SituBreast Lobular Carcinoma In Situ+1 more
Ohio State University Comprehensive Cancer Center 50
Not applicableStudy completedNCT00666731
What this trial is testing

Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer

Who this might be right for
Breast CancerPrecancerous Condition
University of Nebraska 4,945
Testing effectiveness (Phase 2)Study completedNCT05253053
What this trial is testing

To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorCholangiocarcinomaBiliary Tract Cancer+8 more
TransThera Sciences (Nanjing), Inc. 84
Testing effectiveness (Phase 2)Looking for participantsNCT04666961
What this trial is testing

Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ

Who this might be right for
Ductal Carcinoma in SituExtensive DiseaseMastectomy
Institut Cancerologie de l'Ouest 262
Next Page